BRPI0815207A2 - pirimidinas bicíclicas fundidas - Google Patents

pirimidinas bicíclicas fundidas

Info

Publication number
BRPI0815207A2
BRPI0815207A2 BRPI0815207A BRPI0815207A BRPI0815207A2 BR PI0815207 A2 BRPI0815207 A2 BR PI0815207A2 BR PI0815207 A BRPI0815207 A BR PI0815207A BR PI0815207 A BRPI0815207 A BR PI0815207A BR PI0815207 A2 BRPI0815207 A2 BR PI0815207A2
Authority
BR
Brazil
Prior art keywords
fused bicyclic
bicyclic pyrimidines
pyrimidines
fused
bicyclic
Prior art date
Application number
BRPI0815207A
Other languages
English (en)
Inventor
Zülch Armin
Zimmermann Astrid
Beneke Gerrit
Joshi Hemant
Vennemann Matthias
Hölder Swen
Beckers Thomas
Gekeler Volker
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07118736A external-priority patent/EP2050748A1/en
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of BRPI0815207A2 publication Critical patent/BRPI0815207A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BRPI0815207A 2007-08-14 2008-08-14 pirimidinas bicíclicas fundidas BRPI0815207A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1572MU2007 2007-08-14
EP07118736A EP2050748A1 (en) 2007-10-18 2007-10-18 Novel fused pyrimidines
PCT/EP2008/060690 WO2009021992A2 (en) 2007-08-14 2008-08-14 Fused bicyclic pyrimidines

Publications (1)

Publication Number Publication Date
BRPI0815207A2 true BRPI0815207A2 (pt) 2017-03-28

Family

ID=40153211

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0815207A BRPI0815207A2 (pt) 2007-08-14 2008-08-14 pirimidinas bicíclicas fundidas

Country Status (38)

Country Link
US (2) US7776864B2 (pt)
EP (1) EP2188291B1 (pt)
JP (1) JP5344637B2 (pt)
KR (1) KR20100053556A (pt)
CN (1) CN101778851B (pt)
AR (1) AR067945A1 (pt)
AU (1) AU2008288392B2 (pt)
BR (1) BRPI0815207A2 (pt)
CA (1) CA2694058C (pt)
CL (1) CL2008002398A1 (pt)
CO (1) CO6260077A2 (pt)
CR (1) CR11270A (pt)
CY (1) CY1113486T1 (pt)
DK (1) DK2188291T3 (pt)
DO (1) DOP2010000058A (pt)
EA (1) EA020996B1 (pt)
EC (1) ECSP109964A (pt)
ES (1) ES2396177T3 (pt)
HK (1) HK1146273A1 (pt)
HN (1) HN2010000313A (pt)
HR (1) HRP20121022T1 (pt)
IL (1) IL203163A (pt)
MA (1) MA31608B1 (pt)
MX (1) MX2010001746A (pt)
MY (1) MY169738A (pt)
NZ (1) NZ583267A (pt)
PA (1) PA8793201A1 (pt)
PE (1) PE20090944A1 (pt)
PL (1) PL2188291T3 (pt)
PT (1) PT2188291E (pt)
RS (1) RS52559B (pt)
SI (1) SI2188291T1 (pt)
SV (1) SV2010003483A (pt)
TN (1) TN2010000070A1 (pt)
TW (1) TWI439272B (pt)
UA (1) UA99735C2 (pt)
UY (1) UY31293A1 (pt)
WO (1) WO2009021992A2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0717722A2 (pt) * 2006-10-19 2013-10-29 Takeda Pharmaceutical Composto ou um sal do mesmo, pró-droga, ativador de glicoquinase, agente farmacêutico, métodos para ativar uma glicoquinase em um mamífero e para a profilaxia ou o tratamento de diabetes ou obesidade em um mamífero, e, uso do composto ou uma pró-droga do mesmo
BRPI0815207A2 (pt) 2007-08-14 2017-03-28 Bayer Schering Pharma Ag pirimidinas bicíclicas fundidas
US8415376B2 (en) 2008-05-30 2013-04-09 Amgen Inc. Inhibitors of PI3 kinase
ES2435804T3 (es) * 2009-02-13 2013-12-23 Bayer Intellectual Property Gmbh Pirimidinas condensadas como inhibidores de Akt
KR20110114663A (ko) 2009-02-13 2011-10-19 바이엘 파마 악티엔게젤샤프트 융합된 피리미딘
EP2413932A4 (en) * 2009-04-01 2012-09-19 Merck Sharp & Dohme INHIBITORS OF AKT ACTIVITY
JPWO2010125799A1 (ja) 2009-04-27 2012-10-25 塩野義製薬株式会社 Ｐｉ３ｋ阻害活性を有するウレア誘導体
US20130184273A1 (en) * 2010-07-13 2013-07-18 Bayer Intellectual Property Gmbh Bicyclic pyrimidines
JP5926727B2 (ja) 2010-07-28 2016-05-25 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ 置換イミダゾ［１，２−ｂ］ピリダジン
CA2832374A1 (en) 2011-04-07 2012-10-11 Bayer Intellectual Property Gmbh Imidazopyridazines as akt kinase inhibitors
EP2948447B1 (en) 2013-01-23 2016-09-21 Astrazeneca AB Chemical compounds
US20140274685A1 (en) 2013-03-15 2014-09-18 Bayer Cropscience Lp Compositions, additives, and methods for mitigating or controlling seed dust
WO2014146144A2 (en) * 2013-03-15 2014-09-18 Bayer Cropscience Lp Compositions, additives, and methods for mitigating or controlling seed dust
CN111212839A (zh) 2017-09-15 2020-05-29 艾杜罗生物科技公司 吡唑并嘧啶酮化合物及其用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA006483B1 (ru) 2000-06-30 2005-12-29 Уайт Замещенные триазолопиримидины в качестве противораковых средств
US7449488B2 (en) * 2002-06-04 2008-11-11 Schering Corporation Pyrazolopyrimidines as protein kinase inhibitors
US7579355B2 (en) 2003-04-24 2009-08-25 Merck & Co., Inc. Inhibitors of Akt activity
CA2561311A1 (en) * 2004-04-09 2005-10-27 Merck & Co., Inc. Inhibitors of akt activity
AR050188A1 (es) * 2004-08-03 2006-10-04 Uriach Y Compania S A J Compuestos heterociclicos condensados utiles en terapia como inhibidores de quinasas p38 y composiciones farmaceuticas que los contienen
US7544677B2 (en) * 2004-08-23 2009-06-09 Merck & Co., Inc. Inhibitors of Akt activity
JP2008524339A (ja) 2004-12-15 2008-07-10 メルク エンド カムパニー インコーポレーテッド Ａｋｔ活性のインヒビター
AU2005322085B2 (en) 2004-12-28 2012-07-19 Exelixis, Inc. [1H-pyrazolo[3, 4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70S6K, Atk1 and Atk2) for the treatment of immunological, inflammatory and proliferative diseases
US7589068B2 (en) 2005-02-14 2009-09-15 Merck & Co., Inc. Inhibitors of Akt activity
EP1898903B8 (en) 2005-06-10 2013-05-15 Merck Sharp & Dohme Corp. Inhibitors of akt activity
BRPI0815207A2 (pt) 2007-08-14 2017-03-28 Bayer Schering Pharma Ag pirimidinas bicíclicas fundidas
KR20110114663A (ko) * 2009-02-13 2011-10-19 바이엘 파마 악티엔게젤샤프트 융합된 피리미딘

Also Published As

Publication number Publication date
AU2008288392A1 (en) 2009-02-19
AR067945A1 (es) 2009-10-28
US8614218B2 (en) 2013-12-24
HK1146273A1 (en) 2011-05-20
TWI439272B (zh) 2014-06-01
NZ583267A (en) 2012-03-30
TW200922592A (en) 2009-06-01
UA99735C2 (uk) 2012-09-25
HRP20121022T1 (hr) 2013-01-31
CY1113486T1 (el) 2016-06-22
CN101778851A (zh) 2010-07-14
CL2008002398A1 (es) 2009-07-31
PL2188291T3 (pl) 2013-06-28
SV2010003483A (es) 2010-07-06
CA2694058A1 (en) 2009-02-19
JP2010535848A (ja) 2010-11-25
MX2010001746A (es) 2010-03-10
DK2188291T3 (da) 2013-01-07
KR20100053556A (ko) 2010-05-20
CA2694058C (en) 2016-06-07
WO2009021992A3 (en) 2009-04-16
CR11270A (es) 2010-05-19
WO2009021992A2 (en) 2009-02-19
CO6260077A2 (es) 2011-03-22
EP2188291B1 (en) 2012-09-19
US7776864B2 (en) 2010-08-17
MA31608B1 (fr) 2010-08-02
TN2010000070A1 (en) 2011-09-26
PA8793201A1 (es) 2009-04-23
EP2188291A2 (en) 2010-05-26
AU2008288392B2 (en) 2013-10-24
EA201000298A1 (ru) 2010-10-29
RS52559B (en) 2013-04-30
CN101778851B (zh) 2013-05-08
JP5344637B2 (ja) 2013-11-20
ECSP109964A (es) 2010-03-31
EA020996B1 (ru) 2015-03-31
UY31293A1 (es) 2009-03-31
MY169738A (en) 2019-05-14
US20090137607A1 (en) 2009-05-28
IL203163A (en) 2015-01-29
SI2188291T1 (sl) 2013-01-31
US20100184782A1 (en) 2010-07-22
PT2188291E (pt) 2012-12-20
ES2396177T3 (es) 2013-02-19
HN2010000313A (es) 2013-03-18
DOP2010000058A (es) 2010-02-28
PE20090944A1 (es) 2009-08-09

Similar Documents

Publication Publication Date Title
DK2188291T3 (da) Fusionerede bicykliske pyrimidiner
BRPI0815037A2 (pt) Composto bicíclico fundido
DK2154967T3 (da) Pyrimidinderivater
BRPI0809643A2 (pt) Derivados de heteroarila bicíclica fundida
DE112008002410A5 (de) Glasscheiben-Geländer
BRPI1009398A2 (pt) compostos de pirimidina fundida substituída
DE602008002748D1 (de) Linseneinführsystem
BRPI0907435A2 (pt) Derivados de 5-flúor pirimidina
DE602008000004D1 (de) Linseneinführsystem
BRPI0815077A2 (pt) Heterocíclicos fundidos
DK2242743T3 (da) Aminopyrazolderivater
HK1165423A1 (en) Fused pyrimidines
DK1957492T3 (da) Substituerede bicykliske pyrimidonderivater
BRPI0811115A2 (pt) Compostos de heteroarilamida pirimidona
BRPI0920496A2 (pt) derivados substituídos de pirimidina etriazina
CU20090141A7 (es) Compuestos 2-amino pirimidina
BRPI0821142A2 (pt) derivados heterocíclicos bicíclicos
BRPI0811094A2 (pt) Derivados de heteroarilamida pirimidona
BRPI0811611A2 (pt) Compostos de triazolil aminopirimidina
ATE519980T1 (de) Verbinder
CN300862083S (zh) 眼镜
ES1066007Y (es) Gafas
CN300839231S (zh) 眼镜
UA16301S (uk) Стакан
TH97619B (th) แก้ว

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: BAYER PHARMA AKTIENGESELLSCHAFT (DE)

B25A Requested transfer of rights approved

Owner name: BAYER INTELLECTUAL PROPERTY GMBH (DE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2475 DE 12-06-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.